MedPath

Pilot study of effects of cancer survivorship care planning using an AI-based digital platform

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0009302
Lead Sponsor
Inha University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
38
Inclusion Criteria

? Women 19 years of age or older
? Histologically diagnosed with breast cancer
? Have undergone at least one cancer treatment (e.g., surgery, radiation therapy, chemotherapy)
? Expecting to end, or have already ended, planned cancer treatment within one month (except for those taking oral anti-hormonal agents and those receiving monthly targeted therapy)
? Have access to a smartphone
? Those whose next outpatient visit is scheduled within 6 months

Exclusion Criteria

? 2 years have passed since the end of cancer treatment
? Those with evidence of recurrence or metastasis of cancer

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of the QOL Plus intervention: Access to the QOL Plus app, data collection rates, incidence of care plan errors, utilization of educational materials, and overall satisfaction.;Before providing intervention, 1 week after providing intervention;Patient activation: Korean version of the Patient Activation Measure 13 (PAM13-K)
Secondary Outcome Measures
NameTimeMethod
Cancer survivors' self-efficacy: Korean version of the Cancer Survivors' Self-Efficacy Scale (CSSES-K);Health-related quality of life: Korean version of the EORTC QLQ-C30
© Copyright 2025. All Rights Reserved by MedPath